Mark Ibberson
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Diabetes Treatment and Management
Papers in
-
- RNA modifications and cancer 5
- Metabolism, Diabetes, and Cancer 5
- Surgery 22
- Pancreatic function and diabetes 20
- Co-authors
- Bernard Thorens (18 shared papers)Frédéric Burdet (10 shared papers)Marc Uldry (3 shared papers)Ioannis Xénarios (18 shared papers)Masaya Hosokawa (1 shared paper)Robert Lyle (1 shared paper)Michele De Palma (1 shared paper)Mario Leonardo Squadrito (1 shared paper)
- Journals
- Molecular Metabolism (6 papers)Cell Reports (5 papers)Diabetologia (5 papers)Journal of Clinical Investigation (3 papers)PLoS ONE (3 papers)
- Partner nations
- SwitzerlandUnited KingdomUnited States
In The Last Decade
Mark Ibberson
66 papers receiving 3.4k citations
Mark Ibberson's Hit Papers
Peers
Comparison fields: 5 of 122
- Cancer Research 817
- Endocrinology, Diabetes and Metabolism 527
- Molecular Biology 2.0k
- Endocrine and Autonomic Systems 145
- Aging 31
Countries citing papers authored by Mark Ibberson
This map shows the geographic impact of Mark Ibberson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Ibberson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Ibberson more than expected).
Fields of papers citing papers by Mark Ibberson
This network shows the impact of papers produced by Mark Ibberson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Ibberson. The network helps show where Mark Ibberson may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Ibberson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Endogenous RNAs Modulate MicroRNA Sorting to Exosomes and Transfer to Acceptor Cells Hit paper breakdown → | 2014 | 493 |
| 2 | The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans Hit paper breakdown → | 2019 | 391 |
| 3 | 2002 | 261 | |
| 4 | 2014 | 214 | |
| 5 | 2000 | 198 | |
| 6 | 2004 | 192 | |
| 7 | 2004 | 191 | |
| 8 | 2014 | 177 | |
| 9 | 2017 | 173 | |
| 10 | 2020 | 99 | |
| 11 | 2002 | 66 | |
| 12 | 2010 | 58 | |
| 13 | 2017 | 51 | |
| 14 | 2020 | 50 | |
| 15 | 2018 | 48 | |
| 16 | 2015 | 48 | |
| 17 | 2017 | 47 | |
| 18 | 2011 | 45 | |
| 19 | 2016 | 43 | |
| 20 | 2016 | 41 |
About Mark Ibberson
Mark Ibberson is a scholar working on Molecular Biology, Surgery, Genetics, Endocrinology, Diabetes and Metabolism and Immunology, having authored 67 papers that have together received 3.4k indexed citations. Recurring topics across this work include Pancreatic function and diabetes (20 papers), Diabetes and associated disorders (9 papers), Diabetes Management and Research (7 papers), T-cell and B-cell Immunology (6 papers), Adipose Tissue and Metabolism (6 papers), RNA modifications and cancer (5 papers), Metabolism, Diabetes, and Cancer (5 papers) and Cancer-related molecular mechanisms research (5 papers). The work is most often cited by research in Cancer Research (817 citations), Endocrinology, Diabetes and Metabolism (527 citations), Molecular Biology (2.0k citations), Endocrine and Autonomic Systems (145 citations) and Aging (31 citations). Mark Ibberson has collaborated with scholars based in Switzerland, United Kingdom and United States. Frequent co-authors include Bernard Thorens, Frédéric Burdet, Marc Uldry, Ioannis Xénarios, Masaya Hosokawa, Robert Lyle, Michele De Palma, Mario Leonardo Squadrito, Claudio Maderna and Caroline Baer. Their work appears in journals such as Molecular Metabolism, Cell Reports, Diabetologia, Journal of Clinical Investigation and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.